作者
Elena Arbelo, Alexandros Protonotarios, Juan R Gimeno, Eloisa Arbustini, Roberto Barriales-Villa, Cristina Basso, Connie R Bezzina, Elena Biagini, Nico A Blom, Rudolf A de Boer, Tim De Winter, Perry M Elliott, Marcus Flather, Pablo Garcia-Pavia, Kristina H Haugaa, Jodie Ingles, Ruxandra Oana Jurcut, Sabine Klaassen, Giuseppe Limongelli, Bart Loeys, Jens Mogensen, Iacopo Olivotto, Antonis Pantazis, Sanjay Sharma, J Peter Van Tintelen, James S Ware, Juan Pablo Kaski
发表日期
2023/10/1
来源
European heart journal
卷号
44
期号
37
页码范围
3503-3626
出版商
Oxford University Press
简介
• The specific situation of the patient. Unless otherwise provided for by national regulations, off-label use of medication should be limited to situations where it is in the patient’s interest, with regard to the quality, safety, and efficacy of care, and only after the patient has been informed and has provided consent.• Country-specific health regulations, indications by governmental drug regulatory agencies, and the ethical rules to which health professionals are subject, where applicable.
学术搜索中的文章
E Arbelo, A Protonotarios, JR Gimeno, E Arbustini… - European heart journal, 2023
E Arbelo, A Protonotarios, JR Gimeno, E Arbustini… - Eur Heart J, 2023